What is Professional Compounding Centers of America?
PCCA is a comprehensive resource dedicated to supporting independent compounding pharmacists and prescribers in creating personalized medicines. Since its incorporation in 1981, PCCA has provided high-quality products, extensive education, and robust support to over 3,500 pharmacy members across the United States, Canada, Australia, and other international markets. The company's core mission revolves around enabling pharmacists to deliver tailored pharmaceutical solutions that significantly improve patient outcomes. This focus on personalized medicine places PCCA at the forefront of a growing segment within the healthcare industry, addressing the increasing demand for individualized treatment plans.
How much funding has Professional Compounding Centers of America raised?
Professional Compounding Centers of America has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Professional Compounding Centers of America
PPP
Public-Private Partnership
What's next for Professional Compounding Centers of America?
The substantial enterprise-level funding and recent strategic investment signal a robust outlook for Professional Compounding Centers of America. This capital infusion is likely to fuel further development of its product offerings, enhance its educational programs for pharmacists, and expand its global reach. PCCA's commitment to supporting pharmacy compounding suggests a strategic focus on strengthening its infrastructure and potentially exploring new technological advancements in drug formulation and delivery. The company appears poised to capitalize on the expanding market for personalized medicine, reinforcing its role as a key enabler for independent compounding pharmacies worldwide.
See full Professional Compounding Centers of America company page
